Managing rhodesiense human African trypanosomiasis (HAT) in a pregnant patient requires careful consideration of both maternal safety and gestational timing. The presence of pregnancy significantly shapes which therapeutic approaches are appropriate and how urgently they must be initiated.
This protocol applies to pregnant patients diagnosed with rhodesiense human African trypanosomiasis. Pregnancy is a critical comorbidity that directly influences treatment selection and the urgency of intervention, particularly when the mother's clinical condition is compromised.
Specific antiparasitic agents are available for use after the first trimester. When the pregnant woman's general condition is moderately or severely altered, the timing and choice of treatment may shift to prioritise saving the mother's life. The complete regimen, sequencing, and clinical decision points are detailed in the full protocol.